Early administration of <scp>COVID</scp> ‐19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy-Reference-Cited by-同舟云学术

Early administration of COVID ‐19 convalescent plasma with high titer antibody content by live viral neutralization assay is associated with modest clinical efficacy

Published:2022-03-24 Issue:6 Volume:97 Page:770-779
ISSN:0361-8609
Container-title:American Journal of Hematology
language:en
Short-container-title:American J Hematol

Author:

Belov Artur¹,Huang Yin¹,Villa Carlos H.¹,Whitaker Barbee I.¹,Forshee Richard¹,Anderson Steven A.¹,Eder Anne¹,Verdun Nicole¹,Joyner Michael J.²,Wright Scott R.³,Carter Rickey E.⁴,Hung Deborah T.⁵,Homer Mary⁶,Hoffman Corey⁶,Lauer Michael⁷,Marks Peter¹^ORCID,

Affiliation:

1. Center for Biologics Evaluation and Research US FDA Silver Spring Maryland USA

2. Department of Anesthesiology and Perioperative Medicine Mayo Clinic Rochester Minnesota USA

3. Department of Cardiology and the Human Research Protection Program Mayo Clinic Rochester Minnesota USA

4. Department of Quantitative Health Sciences Mayo Clinic Jacksonville Florida USA

5. Infectious Disease and Microbiome Program Broad Institute Cambridge Massachusetts USA

6. Biomedical Advanced Research and Development Authority (BARDA) District of Columbia Washington USA

7. Office of the Director National Institutes of Health Bethesda Maryland USA

Funder

U.S. Department of Health and Human Services

Publisher

Wiley

Subject

Hematology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ajh.26531

Reference70 articles.

1. Mild or Moderate Covid-19

2. COVID‐19 Treatement Guidelines Panel.Coronavirus Disease 2019 (COVID‐19) Treatment Guidelines. National Institutes of Health. Available at:https://www.covid19treatmentguidelines.nih.gov/. Accessed February 2022.

3. The convalescent sera option for containing COVID-19

4. Deployment of convalescent plasma for the prevention and treatment of COVID-19

5. Passive antibody therapy for infectious diseases

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mortality Rates Among Hospitalized Patients With COVID-19 Treated With Convalescent Plasma: A Systematic Review and Meta-Analysis;Mayo Clinic Proceedings: Innovations, Quality & Outcomes;2023-10

2. Longitudinal analysis of anti-SARS-CoV-2 neutralizing antibody (NAb) titers in vaccinees using a novel giant magnetoresistive (GMR) assay;Sensors and Actuators B: Chemical;2023-07

3. Exercise and Experiments of Nature;Comprehensive Physiology;2023-06-26

4. Convalescent plasma therapy in COVID-19: Unravelling the data using the principles of antibody therapy;Expert Review of Respiratory Medicine;2023-05-02

5. High-Throughput Neutralization and Serology Assays Reveal Correlated but Highly Variable Humoral Immune Responses in a Large Population of Individuals Infected with SARS-CoV-2 in the US between March and August 2020;mBio;2023-04-25